- Cat. No.
- A19536
RIG-1 modulator 1
RIG-1 modulator 1 is an anti-viral compound which can be useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV extracted from patent WO 2015172099 A1.
Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
Influenza virus inhibitors act on viral RNA synthesis, nucleoprotein function, the M2 ion channel and host factors. Influenza A and B viruses carry a segmented, negative-sense RNA genome that is transcribed and replicated in the nucleus of infected cells. Favipiravir, a pyrazinecarboxamide, is converted in cells into a ribonucleotide form that inhibits the viral RNA-dependent RNA polymerase. Amantadine hydrochloride blocks the M2 proton channel of influenza A virus, a step required for release of the viral genome. Nucleozin binds the viral nucleoprotein and causes it to aggregate, which prevents its accumulation in the nucleus. Host-directed compounds include SC75741, an inhibitor of nuclear factor kappa B (NF-κB) signaling, and the heat shock protein 90 (Hsp90) inhibitor geldanamycin.
RIG-1 modulator 1 is an anti-viral compound which can be useful for the treatment of viral infections including influenza virus, HBV, HCV and HIV extracted from patent WO 2015172099 A1.